Man Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$252K Buy
+9,803
New +$258K ﹤0.01% 2250
2025
Q3
– Sell
-38,524
Closed -$553K – 2364
2025
Q2
$553K Buy
+38,524
New +$528K ﹤0.01% 1799
2022
Q1
– Sell
-52,583
Closed -$1.43M – 2283
2021
Q4
$1.43M Sell
52,583
-12,865
-20% -$344K ﹤0.01% 1253
2021
Q3
$1.86M Sell
65,448
-5,562
-8% -$169K 0.01% 1193
2021
Q2
$2.14M Buy
71,010
+4,801
+7% +$142K 0.01% 1205
2021
Q1
$1.69M Buy
+66,209
New +$1.7M 0.01% 1160
2020
Q1
– Sell
-347,877
Closed -$9.7M – 1763
2019
Q4
$9.7M Sell
347,877
-83,913
-19% -$2.1M 0.03% 702
2019
Q3
$9.8M Buy
431,790
+213,629
+98% +$4.87M 0.04% 599
2019
Q2
$5.5M Buy
218,161
+126,987
+139% +$3.41M 0.02% 909
2019
Q1
$2.48M Sell
91,174
-97,091
-52% -$3.26M 0.01% 1236
2018
Q4
$6.21M Sell
188,265
-340,492
-64% -$13.7M 0.03% 658
2018
Q3
$24.7M Buy
528,757
+194,334
+58% +$8.92M 0.09% 248
2018
Q2
$14.5M Buy
334,423
+184,748
+123% +$8.85M 0.06% 399
2018
Q1
$8.33M Buy
+149,675
New +$8.2M 0.04% 578

Other funds holding MD

Man Group's MD Position: Q3 2026 in Review

Man Group opened a new position in Pediatrix Medical (MD) in Q3 2026: 9,803 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #2250 among its holdings. This is a return to the name: Man Group previously reported a position in MD as recently as Q2 2025.

Man Group first reported a position in MD in Q1 2018 and has held it in 14 quarters since. The position peaked at $24.7M in Q3 2018. 311 funds tracked by Wall St. Rank hold MD as of Q3 2026.

  • Man Group held 9,803 shares of Pediatrix Medical worth $252K as of Q3 2026.
  • Pediatrix Medical was a new Man Group position in Q3 2026.
  • Pediatrix Medical made up ﹤0.01% of Man Group's portfolio in Q3 2026, its #2250 holding.
  • Man Group first reported a position in Pediatrix Medical in Q1 2018 and has held it in 14 quarters since.
  • Man Group's Pediatrix Medical position peaked at $24.7M in Q3 2018.
  • 311 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2026.

Based on Man Group's 13F filing for Q3 2026, filed 16 Nov 2026.